NCT00600600View on ClinicalTrials.gov

Tigecycline for Treatment of Rapidly Growing Mycobacteria

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

April 30, 2010

Study Completion Date

December 31, 2010

Conditions
Mycobacterium Abscessus Lung DiseaseRapidly Growing Mycobacterial Lung Disease
Interventions
DRUG

Tigecycline

Tigecycline dosage based on age and clinical status of patient.

Trial Locations (1)

75708

The University of Texas Health Science Center at Tyler, Tyler

All Listed Sponsors
collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

The University of Texas Health Science Center at Tyler

OTHER

NCT00600600 - Tigecycline for Treatment of Rapidly Growing Mycobacteria | Biotech Hunter | Biotech Hunter